Topics

Biotech Report: Mologen (MGNK) insolvent, MorphoSys (MOR) fest

12:52 EST 4 Dec 2019 | FinanzNachrichten

(shareribs.com) Frankfurt / New York 04.12.2019 - Biotech-Aktien zeigen sich im deutschen Handel durchwachsen. Nach dem Insolvenzantrag sacken die Papiere von Mologen weg. MorphoSys können zulegen....

Original Article: Biotech Report: Mologen (MGNK) insolvent, MorphoSys (MOR) fest

NEXT ARTICLE

More From BioPortfolio on "Biotech Report: Mologen (MGNK) insolvent, MorphoSys (MOR) fest"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...